Key facts
- This page summarizes TPG GP A, LLC's Form 4 filing for Odyssey Therapeutics, Inc. (ODTX).
- 6 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 13 May 2026, 17:10.
TPG GP A, LLC - 11 May 2026 Form 4 Insider Report for Odyssey Therapeutics, Inc. (ODTX)
- Reporting relationship
- Former 10% Owner
- Issuer ticker
- ODTX
- Reported as of
- 11 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 May 2026, 17:10:38 UTC
- Prior SEC filing
- 07 May 2026
- Next SEC filing
- 14 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew White, Vice President, TPG GP A, LLC (8)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
TPG GP A, LLC filed Form 4 for Odyssey Therapeutics, Inc. (ODTX) on 13 May 2026.
Change
- Previous filing in this sequence was filed on 07 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (3)
CIK 0001903793
Primary reporting owner
TPG GP A, LLC
- Relationship
- Former 10% Owner
- Address
- C/O TPG INC., 301 COMMERCE STREET, SUITE 3300, FORT WORTH
- Signature
- /s/ Matthew White, Vice President, TPG GP A, LLC (8)
- Signature date
- 13 May 2026
CIK 0001099776
COULTER JAMES G
- Relationship
- Former 10% Owner
- Address
- C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH
- Signature
- /s/ Gerald Neugebauer on behalf of James G. Coulter (8) (9)
- Signature date
- 13 May 2026
CIK 0001366946
WINKELRIED JON
- Relationship
- Former 10% Owner
- Address
- C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH
- Signature
- /s/ Gerald Neugebauer on behalf of Jon Winkelried (8) (9)
- Signature date
- 13 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ODTX
transaction
Common Stock
Other
- Transaction value
- Shares
- +423,111
- Change %
- Price
- Shares after
- 423,111
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Common Stock
Other
- Transaction value
- Shares
- +423,111
- Change %
- Price
- Shares after
- 423,111
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Common Stock
Other
- Transaction value
- Shares
- +423,111
- Change %
- Price
- Shares after
- 423,111
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Common Stock
Other
- Transaction value
- Shares
- -2,351
- Change %
- -0.56%
- Price
- $18.00*
- Shares after
- 420,760
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Common Stock
Other
- Transaction value
- Shares
- -2,351
- Change %
- -0.56%
- Price
- $18.00*
- Shares after
- 420,760
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Common Stock
Other
- Transaction value
- Shares
- -2,351
- Change %
- -0.56%
- Price
- $18.00*
- Shares after
- 420,760
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,880,497
- Change %
- +447%
- Price
- Shares after
- 2,301,257
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F4, F6, F7
ODTX
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,880,497
- Change %
- +447%
- Price
- Shares after
- 2,301,257
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F4, F6, F7
ODTX
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,880,497
- Change %
- +447%
- Price
- Shares after
- 2,301,257
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F4, F6, F7
ODTX
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +1,388,889
- Change %
- +60%
- Price
- $18.00*
- Shares after
- 3,690,146
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F5, F6, F7
ODTX
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +1,388,889
- Change %
- +60%
- Price
- $18.00*
- Shares after
- 3,690,146
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F5, F6, F7
ODTX
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +1,388,889
- Change %
- +60%
- Price
- $18.00*
- Shares after
- 3,690,146
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F5, F6, F7
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ODTX
transaction
Derivative
Warrants (right to buy)
Other
- Transaction value
- Shares
- -423,111
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Underlying class
- Common Stock
- Underlying amount
- 423,111
- Exercise price
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Derivative
Warrants (right to buy)
Other
- Transaction value
- Shares
- -423,111
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Underlying class
- Common Stock
- Underlying amount
- 423,111
- Exercise price
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Derivative
Warrants (right to buy)
Other
- Transaction value
- Shares
- -423,111
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Underlying class
- Common Stock
- Underlying amount
- 423,111
- Exercise price
- Footnotes
- F1, F2, F3, F6, F7
ODTX
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -18,272,789
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Underlying class
- Common Stock
- Underlying amount
- 1,880,497
- Exercise price
- Footnotes
- F1, F2, F4, F6, F7
ODTX
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -18,272,789
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Underlying class
- Common Stock
- Underlying amount
- 1,880,497
- Exercise price
- Footnotes
- F1, F2, F4, F6, F7
ODTX
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -18,272,789
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 May 2026
- Ownership
- See Explanation of Responses
- Underlying class
- Common Stock
- Underlying amount
- 1,880,497
- Exercise price
- Footnotes
- F1, F2, F4, F6, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
TPG GP A, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 7 footnotes
Footnote F1
Each of James G. Coulter and Jon Winkelried own entities that control TPG GP A, LLC (together with Messrs. Coulter and Winkelried, the "Reporting Persons"), which exercises direct or indirect control over entities that collectively hold 100% of the shares of Class B common stock (which represents a majority of the combined voting power of the common stock) of TPG Inc., which is the sole member of TPG GPCo, LLC, which is the sole member of TPG Holdings II-A, LLC, which is the general partner of TPG Operating Group II, L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Operating Group I, L.P., which is the sole member of TPG LSI GenPar Advisors, LLC, which is the general partner of TPG LSI GenPar, L.P., which is the sole member of TPG LSI SPV GP, LLC.
Footnote F2
TPG LSI SPV GP, LLC is the general partner of each of (i) TPG LSI Rise Orazio, L.P. ("TPG Orazio I"), which directly holds 2,301,257 shares of Common Stock ("Common Stock") of Odyssey Therapeutics, Inc. (the "Issuer"), and (ii) TPG LSI Rise Orazio II, L.P. ("TPG Orazio II" and, together with TPG Orazio I, the "TPG Funds"), which directly holds 1,388,889 shares of Common Stock.
Footnote F3
The Warrants to Purchase Common Stock (the "Warrants") directly held by TPG Orazio I were, pursuant to their terms, deemed automatically exercised, by way of a cashless net issue exercise, for shares of Common Stock upon consummation of the Issuer's initial public offering on May 11, 2026. Each Warrant had been exercisable for one share of Common Stock at an exercise price of $0.10 until the earlier of (i) June 16, 2032 and (ii) a "Corporate Transaction" (defined as the consummation of a Deemed Liquidation Event (as defined in the Issuer's Certificate of Incorporation (as defined below)) and the closing of the Issuer's initial public offering).
Footnote F4
Pursuant to the Eighth Amended and Restated Certificate of Incorporation (the "Certificate of Incorporation") of the Issuer, as amended, the shares of Series D Preferred Stock of the Issuer (the "Preferred Stock") directly held by TPG Orazio I automatically converted into shares of Common Stock upon consummation of the Issuer's initial public offering on May 11, 2026 at a conversion rate (as adjusted for a reverse stock split) equal to one share of Common Stock per 9.7170 shares of Preferred Stock. The shares of Preferred Stock had previously been convertible, at the option of the holder, at any time into shares of Common Stock.
Footnote F5
On May 11, 2026, in connection with the Issuer's initial public offering, TPG Orazio II acquired an aggregate of 1,388,889 shares of Common Stock at a price of $18.00 per share.
Footnote F6
Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each of the TPG Funds and each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such TPG Fund's or such Reporting Person's pecuniary interest therein, if any.
Footnote F7
Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.
SEC remarks
(8) The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. (9) Gerald Neugebauer is signing on behalf of Messrs. Coulter and Winkelried pursuant to authorization and designation letters dated January 10, 2024, which were previously filed with the Securities and Exchange Commission.